Clinical Trials in Atlanta

Showing 15201-15220 of 19,805 trials

Adult Accuracy Study of the Enlite 3 Glucose Sensor

NCT02246582

The purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and 640G Pump in subjects aged 14-75 years with type 1 or type 2 diabetes.

Type 1 DiabetesType 2 Diabetes

Medtronic MiniMed, Inc.118 participantsStarted Sep 2014

Escondido, California, United States • Walnut Creek, California, United States • Aurora, Colorado, United States +3 more locations

COMPLETEDPhase 3< 1 mile

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

NCT00077597

This study will assess the efficacy and safety of Mircera given intravenously in the treatment of renal anemia in chronic kidney disease patients on dialysis who are not currently receiving epoetin or any other erythropoietic substance. The anticipated time on study treatment is 1-2 years and the target sample size is 100-500 individuals.

Anemia

Hoffmann-La Roche182 participantsStarted Feb 2004

Davis, California, United States • Lakewood, Colorado, United States • Atlanta, Georgia, United States +56 more locations

Adult Accuracy Study of the Enlite 3 Glucose Sensor

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

Find Trials by Condition in Atlanta

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients

A Study of R547 in Patients With Advanced Solid Tumors.

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors

A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors